483 Response Catalent Maryland Jun 2020

Andrew Byrnes FDA, Bo Liang FDA, Wanda Pagan FDA, Priscilla Pastrana FDA$119.00 - Available Now

FDA investigators audited the Catalent Maryland - Harmans, MD, United States facility and issued inspectional observation (via FDA 483) on 19 Jun 2020.

Product details

  • Category:
  • Inspection end: 19 Jun 2020
  • Location: Harmans, United States
  • FEI: 3015434301
Add To Cart